Notify me when Jeffrey Matthew Gryga Irrevocable Trust files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TOVX | Theriva Biologics, Inc. | Common stock | 7.7% | $300,046 | 739,211 | Jeffrey Matthew Gryga Irrevocable Trust | 24 Oct 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|